ArticlePharmaceuticals (Basel, Switzerland)2021

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations.

Sara Malaca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.